Organization
Reistone Biopharma
9 clinical trials
Clinical trial
A Randomized, Double Blind and Placebo Controlled Phase 3 Study to Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2022-08-12
Clinical trial
A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR1459 Tablets in the Treatment of Primary Membranous Nephropathy (PMN)Status: Active (not recruiting), Estimated PCD: 2023-08-28
Clinical trial
A Randomized, Double-Blinded, and Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia AreataStatus: Active (not recruiting), Estimated PCD: 2023-10-31
Clinical trial
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
An Open Label Phase II Clinical Trial Evaluating the Efficacy and Safety of SHR1459 in Adult Patients With Neuromyelitis Optical Spectrum Disorders (NMOSDs)Status: Completed, Estimated PCD: 2022-08-15
Clinical trial
A Phase II Randomized, Placebo Controlled, Double-blind, 4 Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Ulcerative Colitis.Status: Completed, Estimated PCD: 2020-11-30
Clinical trial
A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's DiseaseStatus: Completed, Estimated PCD: 2021-09-16
Clinical trial
A Randomized, Double-blind, Vehicle-Controlled, Seamless and Adaptive-designed Phase II/III Study to Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Adult Patients With Mild-to-Moderate Atopic DermatitisStatus: Active (not recruiting), Estimated PCD: 2023-09-08
Clinical trial
A Randomized, Double-Blind and Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Moderate to Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2020-08-21